Related Experiment Videos
Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases
T L Yue1, E H Ohlstein, R R Ruffolo
1Department of Cardiovascular Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, USA.
Abstract:
The realization that apoptosis is genetically programmed raises the exciting prospect that modulating apoptosis may provide novel approaches for treatment of cardiovascular diseases in which apoptosis has been demonstrated. Low molecular weight inhibitors of caspases and mitogen-activated protein kinases have been evaluated, with promising results in a variety of cardiovascular apoptotic models.
Insights
Modulating genetically programmed cell death (apoptosis) offers new cardiovascular disease treatments. Inhibitors targeting caspases and mitogen-activated protein kinases show promise in preclinical models.
Area of Science:
- Biomedical Science
- Molecular Biology
- Cardiovascular Research
Background:
- Apoptosis, or programmed cell death, is genetically controlled.
- Dysregulated apoptosis contributes to cardiovascular diseases.
- Targeting apoptotic pathways presents therapeutic opportunities.
Purpose of the Study:
- To explore the potential of modulating apoptosis for treating cardiovascular diseases.
- To evaluate the efficacy of specific molecular inhibitors in cardiovascular apoptotic models.
Main Methods:
- Utilizing low molecular weight inhibitors.
- Focusing on caspase and mitogen-activated protein kinase pathways.
- Testing in various cardiovascular apoptotic models.
Main Results:
- Promising results observed in preclinical cardiovascular models.
- Demonstrated potential of caspase and MAPK inhibitors.
Conclusions:
- Modulating apoptosis is a viable strategy for cardiovascular disease treatment.
- Caspase and MAPK inhibitors are promising therapeutic agents.